The new equity financing will support PlasmaGen Biosciences’ international expansion and enhance its portfolio of plasma-derived therapeutics, following a total of ₹600 crore raised since 2010.
The new equity financing will support PlasmaGen Biosciences’ international expansion and enhance its portfolio of plasma-derived therapeutics, following a total of ₹600 crore raised since 2010. by Soban News (international And National News)
